Botox Safety: Risks, Side Effects & Safe Treatment Planning

Clinical guidance from Dr Nyla Raja MBChB (Hons), MRCGP (Dist), DFFP, DPDermatology - GMC No. 6057913

Botox Safety: At a Glance

Botox® and other botulinum toxin type A treatments are established prescription-only medicines used in both aesthetic and medical practice, with an established safety profile when appropriately prescribed and administered. Patient safety depends on appropriate prescribing, medical assessment, facial anatomy, product selection, dose, injection placement, hygiene, informed consent, and the ability to recognise and manage complications where necessary.

Most aesthetic side effects are temporary and localised, such as redness, tenderness, bruising, headache, or short-term changes in muscle activity. Less common effects can include asymmetry or unwanted weakening of a neighbouring muscle, such as temporary eyelid or eyebrow drooping. Rare but potentially serious complications can also occur and should be discussed as part of informed consent.

• Before treatment: medical history, medicines, previous treatments, facial anatomy, muscle activity, suitability, and treatment goals should be assessed.
• Prescription: botulinum toxin is a prescription-only medicine in the UK and should only be supplied and administered following an appropriate clinical assessment and prescription.
• During treatment: product authenticity, appropriate storage, dose, anatomical placement, aseptic technique, and practitioner competence all matter.
• After treatment: patients should understand expected effects, possible complications, when to contact the clinic, and which symptoms require urgent medical attention.

Suitability for Botox treatment is individual. A consultation should establish whether treatment is clinically appropriate rather than assuming that every patient requesting an injectable treatment should proceed.

 

Is Botox Safe?

Botulinum toxin type A has an established safety profile when appropriately prescribed and administered, and has been used for many years across both medical and aesthetic practice. However, no prescription medicine or injectable procedure is completely without risk.

In aesthetic treatment, botulinum toxin temporarily reduces signalling between selected nerves and muscles. This can soften dynamic lines caused by repeated facial expression, including forehead lines, frown lines, and crow’s feet.

Safety depends not only on the medicine itself, but on the decisions surrounding its use: whether treatment is appropriate for the patient, which muscles should be treated, the dose used, where injections are placed, the product administered, and whether the practitioner understands how to identify and manage an unwanted effect.

This distinction is important. The clinical objective is not simply to administer a standard number of injections. It is to produce a controlled effect in selected muscles while preserving appropriate function, expression, and facial balance.

 

Why Is Botox a Prescription-Only Medicine?

Botulinum toxin products are prescription-only medicines in the UK. This means treatment requires an appropriate prescription rather than being treated in the same way as a non-prescription cosmetic service.

The prescribing process matters because it creates an opportunity to assess whether the medicine is suitable for the individual patient, consider contraindications and interactions, determine the appropriate treatment plan, and ensure that the person receiving treatment understands its benefits and risks.

GMC prescribing guidance for cosmetic injectable medicines states that doctors must physically examine a patient before prescribing non-surgical cosmetic medicines such as Botox and must not prescribe these medicines remotely.

The prescription should therefore never be viewed as an administrative formality. It is part of the clinical safety process.

Can Botox Be Prescribed Online?

For doctors practising under GMC guidance, injectable cosmetic medicines such as Botox require a physical examination before prescribing. They should not be prescribed solely through a telephone, video, or online consultation.

A digital enquiry or preliminary consultation may help a patient obtain information, but it does not replace the clinical assessment required before a prescription is issued.

Does the Prescriber Have to Perform the Injection?

The prescriber and treating practitioner are not necessarily required to be the same person in every clinical model. However, where administration is delegated, the prescriber remains responsible for appropriate prescribing and must be satisfied that the individual providing treatment has the necessary training, competence, and experience.

Patients should know who has assessed them, who has prescribed the medicine, and who will be carrying out their treatment.

Consultation and Medical History Before Botox

A Botox consultation should establish much more than which lines a patient would like to soften.

A relevant medical history can identify circumstances that change the risk-benefit balance or mean treatment should be postponed. Your practitioner may ask about:

• Current and previous medical conditions
• Prescription medicines and supplements
• Allergies or previous reactions to medicines
• Previous Botox or other botulinum toxin treatments
• Previous adverse reactions or unexpected treatment results
• Neurological or neuromuscular conditions
• Problems with swallowing or breathing
• Previous facial surgery or significant facial injury
• Active skin infection or inflammation around the proposed injection sites
• Pregnancy or breastfeeding
• Other recent injectable, dental, medical, or aesthetic treatment where relevant

This information should be considered alongside the patient’s facial anatomy and treatment goals.

Patients should give an accurate history even if they believe a condition or medicine is unrelated to Botox. Decisions about relevance are best made by the prescribing clinician.

Previous Botox Treatment Matters

Previous treatment should also be discussed, including approximately when it was performed, which areas were treated, how the patient responded, and whether they experienced unwanted weakness, asymmetry, eyelid drooping, or other effects.

This can help the practitioner understand the patient’s previous response and avoid simply repeating a treatment pattern that may not be appropriate.

Why Practitioner Qualifications Matter

Injecting botulinum toxin requires more than the ability to place a needle into a muscle. Safe treatment depends on clinical assessment, prescribing standards, anatomy, pharmacology, dose selection, injection technique, infection prevention, and the ability to identify an adverse effect.

GMC guidance on cosmetic interventions emphasises practitioner competence, informed consent, evidence-based treatment, appropriate clinical environments, and systems for managing complications.

When considering a practitioner, it is reasonable to understand:

• Their professional qualification and registration
• Their training and experience in botulinum toxin treatment
• Who will prescribe the medicine
• Who will perform the injections
• Whether treatment takes place within an appropriately equipped clinical setting
• How follow-up is provided
• What happens if there is an unexpected result or complication

A practitioner should also recognise the limits of their competence. Some presentations require further assessment, a different treatment strategy, or referral rather than injection.

 

Why Facial Anatomy Matters for Botox Safety

Botox treatment works by changing muscle activity. Understanding the anatomy and function of the muscles being treated is therefore fundamental.

Facial muscles do not work independently. They interact to elevate, depress, and position the eyebrows, eyelids, lips, and other facial structures. Reducing one muscle’s activity can alter the relative effect of another.

For example, treatment of the forehead requires consideration of the relationship between the frontalis muscle, which elevates the eyebrows, and muscles that pull the brows downward. Excessive weakening or poorly selected injection placement can produce unwanted heaviness or changes in eyebrow position.

Similarly, treatment around the eyes, nose, mouth, or lower face requires an understanding of neighbouring muscles and structures because small differences in placement can alter function or expression.

Facial Anatomy Is Individual

Muscle size, strength, position, movement pattern, eyebrow shape, facial asymmetry, and compensatory muscle activity vary from one patient to another.

This is why fixed injection maps should not replace individual assessment. Two patients concerned about the same forehead line may require different injection points and different doses.

Botox Dose and Injection Placement

Dose and placement are closely connected. The amount of botulinum toxin required depends on the product being used, the muscle being treated, its strength, the patient’s anatomy, and the intended clinical effect.

Using too little may produce insufficient effect. Using more than is appropriate does not necessarily improve the aesthetic result and may increase the likelihood of excessive or unwanted muscle weakness.

The aim is therefore not to use the greatest possible dose, but the dose considered appropriate for the patient and treatment area.

Why Injection Placement Matters

Botulinum toxin affects muscle activity around the site where it is administered. Injection depth, position, dose, and proximity to neighbouring structures all influence the result.

Unwanted effects can occur when the action of the medicine involves a neighbouring muscle. Depending on the area treated, this can contribute to temporary eyebrow or eyelid drooping, smile asymmetry, or unwanted weakness.

Careful anatomical assessment and conservative planning are therefore part of risk reduction.

Botulinum Toxin Products Are Not Dose-for-Dose Interchangeable

Different authorised botulinum toxin products have their own dosing information, characteristics, and licensed indications. Their units should not be assumed to be directly interchangeable.

The practitioner should understand the particular product being prescribed and follow the relevant clinical and product guidance rather than applying the same numerical dose across different brands.

Genuine Product Sourcing and Storage

Product provenance is another important part of botulinum toxin safety.

Medicines should be obtained through appropriate legitimate supply channels, stored according to the manufacturer’s requirements, and used within the relevant product instructions. Patients should not be exposed to products of uncertain origin simply because they appear cheaper or are promoted under a familiar name.

The MHRA’s botulinum toxin safety guidance specifically warns about the risks associated with unlicensed and counterfeit botulinum toxin products and advises patients to check that the product being used is licensed for use in the UK.

The MHRA has also confirmed that authorised botulinum toxin products have product-specific dosing and administration information and that units are not interchangeable between products.

At Dr Nyla Medispa, Botox treatment is provided as a prescription medical treatment within a medically regulated clinical setting.

 

Why the Word “Botox” Can Cause Confusion

Botox® is a specific brand name, although the word “Botox” is often used more broadly in everyday conversation to describe botulinum toxin injections.

Patients should know which actual medicine they are receiving rather than assuming that every botulinum toxin product is identical.

Hygiene and Injection Technique

Botox treatment involves multiple injections through the skin, so appropriate hygiene and aseptic practice are necessary even though the injection points are small.

Clinical measures may include:

• Hand hygiene
• Appropriate preparation of the treatment area
• Single-use sterile needles and injection equipment
• Appropriate handling and preparation of the medicine
• A clean and suitably equipped clinical environment
• Avoiding injection through active infection or significantly compromised skin

The practitioner should also use a technique appropriate to the muscle and treatment area. Needle position, angle, depth, and dose should reflect the anatomy rather than follow a purely cosmetic template.

Who May Not Be Suitable for Botox?

Not every patient requesting Botox will be suitable for treatment.

Contraindications and precautions vary according to the specific botulinum toxin medicine, which is why product information and individual medical assessment are important.

Factors that may make treatment unsuitable, require additional medical consideration, or influence the decision to proceed can include:

• Known hypersensitivity to the relevant botulinum toxin product or its ingredients
• Active infection at a proposed injection site
• Certain neurological or neuromuscular disorders
• Existing swallowing or respiratory problems where clinically relevant
• Medicines that may affect neuromuscular transmission
• Previous significant adverse reactions to botulinum toxin
• Pregnancy or breastfeeding in the context of elective aesthetic treatment
• Other medical circumstances in which the prescriber considers treatment inappropriate

This is not an exhaustive list. Suitability should be assessed against the specific medicine being prescribed and the patient’s complete medical history. For a more detailed explanation of the factors that determine whether treatment is appropriate, including age, muscle activity, medical history, pregnancy and breastfeeding, medications, and treatment expectations, see our guide to who is suitable for Botox and when treatment may not be appropriate.

When Should Botox Be Delayed or Declined?

A clinically responsible consultation can result in treatment being postponed or declined.

Examples may include an active infection affecting the intended treatment area, an unresolved medical issue requiring further assessment, uncertainty about previous reactions, or circumstances in which treatment is unlikely to provide an appropriate benefit.

Treatment may also be inappropriate when the requested result cannot realistically be achieved with botulinum toxin or when attempting to meet the patient’s expectations would require excessive muscle weakening.

More Treatment Is Not Always Better

Patients sometimes request a completely movement-free appearance. This may not be compatible with maintaining natural facial function or balance.

Some muscle activity has functional and aesthetic value. The appropriate degree of movement after treatment depends on anatomy, treatment goals, and clinical judgement.

A practitioner should be prepared to recommend a smaller treatment, a different approach, or no treatment when that represents better clinical care.

 

Informed Consent Before Botox

Consent is not simply signing a form immediately before injections.

Before treatment, patients should have an opportunity to understand:

• What medicine is being proposed
• Why it is being recommended
• The areas and muscles being considered
• The expected effect and limitations of treatment
• Common temporary side effects
• Less common and rare complications
• Relevant alternatives, including no treatment
• Expected onset and duration
• Aftercare and follow-up arrangements
• What to do if a complication or unexpected effect occurs

GMC cosmetic intervention standards require doctors carrying out cosmetic procedures to discuss outcomes, benefits, risks, and alternatives, and to give patients sufficient information and time to make an informed decision.

Patients should be able to ask questions and should not feel pressured to proceed because a consultation has taken place.

Botox Side Effects and Complications

Most side effects following aesthetic Botox treatment are mild and temporary, but the exact risk profile depends on the area treated, dose, product, and individual patient. For a more detailed explanation of expected reactions, less common effects, and symptoms that require clinical review, see our guide to Botox side effects and when to seek advice.

Common Temporary Effects

Possible short-term effects can include:

• Redness at injection points
• Mild swelling
• Tenderness
• Bruising
• Small temporary injection marks
• Headache in some patients

These effects generally settle as the injection sites recover.

Temporary Unwanted Muscle Weakness

Because botulinum toxin works by reducing muscle activity, an unwanted effect can occur if a neighbouring muscle is affected or if the treatment alters the balance of facial muscle activity more than intended.

Depending on where treatment has been performed, potential effects can include:

• Eyelid drooping
• Changes in eyebrow position
• Facial asymmetry
• Unwanted weakness around the treatment area
• Changes in expression

These effects are usually temporary because the action of botulinum toxin itself gradually wears off, but they should still be assessed by the treating clinic.

Rare Spread of Botulinum Toxin Effect

Botulism caused by therapeutic or cosmetic botulinum toxin treatment is rare, but it can be serious. In July 2026, the MHRA issued updated safety advice following reports of iatrogenic botulism, where the toxin’s effect extends beyond the intended treatment area.

Potential symptoms can include:

• Difficulty swallowing
• Difficulty speaking or slurred speech
• Breathing difficulty or shortness of breath
• Generalised muscle weakness

The MHRA advises that these symptoms can develop days after treatment and, in rare circumstances, may present later. Anyone developing symptoms suggestive of botulism following botulinum toxin treatment should seek immediate medical attention.

If you develop difficulty breathing, significant difficulty swallowing, severe generalised weakness, or other symptoms suggesting a medical emergency after treatment, call 999.

Follow-Up After Botox Treatment

Botox does not reach its final effect immediately. Muscle activity changes gradually after treatment, so the result should not be judged in the first few hours.

Follow-up allows the practitioner to assess the clinical response once the medicine has had sufficient time to take effect, particularly where there is concern about asymmetry, insufficient response, or an unexpected change in muscle activity. For more detail on expected onset, when the full effect usually develops, and how movement gradually returns, see our guide to how long Botox lasts and when results start.

A review should consider the patient’s facial movement rather than automatically adding more product because one line remains visible.

Static lines that are present when the face is at rest may not disappear completely simply because the underlying muscle movement has been reduced. Skin quality, line depth, age, and duration of the crease all influence the appearance.

If you are concerned about your recovery or treatment result, contact our clinical team rather than attempting to correct the result elsewhere before it has been appropriately assessed.

Why Complication Protocols Matter

Safe Botox practice does not end after the injections have been administered. Clinics should have clear processes for handling questions, unexpected effects, adverse reactions, and medical complications.

This includes being able to:

• Provide patients with appropriate aftercare information
• Offer a clear route for clinical contact
• Assess unexpected weakness or asymmetry
• Recognise symptoms that require urgent medical care
• Escalate treatment appropriately where necessary
• Document the product, batch information, dose, and injection sites appropriately
• Report relevant suspected medicine adverse reactions through appropriate pharmacovigilance systems

GMC safety and quality guidance for cosmetic interventions states that patients should be told how to report complications and adverse reactions and that practitioners should have systems supporting patient safety and quality of care.

This matters because some problems can only be managed appropriately when the practitioner understands what was injected, how much was used, and where it was placed.

Continuity of Care Matters

Patients should know how to obtain advice after leaving the clinic. A treatment provider should not become difficult to contact once the procedure has been completed.

If you have a non-emergency concern following Botox treatment at Dr Nyla Medispa, you can contact our clinical team or call 0800 009 6661.

Symptoms suggestive of a serious medical emergency should be directed to 999.

What Should You Look for When Choosing a Botox Clinic?

The safety of Botox treatment cannot be assessed solely from treatment price or before-and-after photographs.

Useful questions include:

• Who will medically assess me?
• Who will prescribe my botulinum toxin?
• Who will carry out the injections?
• What are their qualifications and professional registration?
• Which botulinum toxin product will be used?
• Is the medicine authorised and sourced through legitimate channels?
• How will my facial anatomy and muscle movement be assessed?
• What risks are relevant to my treatment?
• What follow-up is available?
• Who do I contact if I develop an unexpected effect?

The NHS guidance on choosing a cosmetic practitioner also advises patients receiving botulinum toxin to establish who the prescriber is, who will administer the treatment, and what training and experience they have.

A consultation should provide enough information to make an informed decision without pressure to proceed immediately.

Book in a Free Consultation With Our Expert Team

• Award-winning, doctor-led aesthetic clinics
• Locations in London, Cheshire, and Liverpool
• Over 50 non-surgical treatments available
• Free consultation with a personalised plan

Book a Consultation

Botox Safety FAQs

Is Botox safe?

Botulinum toxin has an established safety profile when appropriately prescribed and administered, but it is not risk-free. Safe treatment depends on patient selection, medical assessment, practitioner competence, facial anatomy, dose, product selection, injection placement, hygiene, and appropriate follow-up.

Is Botox a prescription-only medicine in the UK?

Yes. Botulinum toxin products are prescription-only medicines in the UK. A prescription should follow an appropriate clinical assessment rather than being treated as an administrative step.

Can a doctor prescribe Botox through a video consultation?

GMC guidance requires doctors to physically examine patients before prescribing injectable cosmetic medicines such as Botox. Doctors should therefore not prescribe these medicines solely by telephone, video, or online consultation.

What are the most common side effects of Botox?

Temporary redness, mild swelling, tenderness, bruising, injection marks, and headache can occur. Depending on treatment area and placement, temporary unwanted muscle weakness or asymmetry is also possible.

Can Botox make an eyelid droop?

Temporary eyelid drooping, or ptosis, is a recognised potential complication. Risk depends on factors including anatomy, dose, injection placement, and treatment area. If you notice eyelid or eyebrow changes after treatment, contact your treating practitioner for assessment.

Can Botox cause botulism?

Iatrogenic botulism following botulinum toxin treatment is rare, but it is recognised and can be serious. Symptoms can include difficulty swallowing, slurred speech, breathing difficulty, and generalised muscle weakness. These symptoms require urgent medical attention.

How can I tell whether Botox is genuine?

Patients can ask which specific botulinum toxin medicine is being used and who prescribed it. Medicines should be sourced through legitimate channels and appropriately stored. The MHRA has warned that unlicensed and counterfeit botulinum toxins may significantly increase the risk of adverse reactions.

Does everyone receive the same Botox dose?

No. Dose should be selected according to the particular product, muscle strength, treatment area, individual anatomy, previous response, and intended effect. A standard dose or identical injection map is not appropriate for every face.

Who should avoid Botox?

Suitability varies according to medical history and the particular botulinum toxin medicine being considered. Certain allergies, active injection-site infection, neuromuscular conditions, medicines, previous reactions, pregnancy or breastfeeding, and other medical circumstances can influence whether treatment is appropriate.

Can Botox treatment be refused?

Yes. A medical practitioner may advise against treatment if it is contraindicated, medically inappropriate, unlikely to achieve the requested result safely, or inconsistent with appropriate clinical care. Safe aesthetic practice includes being prepared not to treat.

What should I do if I am worried after Botox?

For a non-emergency concern following treatment, contact our clinical team. If you develop symptoms such as significant difficulty breathing or swallowing, severe generalised weakness, or another medical emergency, seek immediate emergency medical attention by calling 999.

Botox Safety at Dr Nyla Medispa

Responsible Botox treatment is not based on assuming that a familiar medicine is free from risk. It is based on appropriate prescribing, careful patient selection, detailed facial assessment, anatomical knowledge, individualised dosing, genuine product sourcing, appropriate clinical technique, informed consent, and access to follow-up.

At Dr Nyla Medispa, Botox treatment is provided within a medically regulated setting and planned according to the patient’s medical history, facial anatomy, muscle activity, and treatment goals. Our approach is focused on appropriate muscle relaxation while preserving facial balance and natural-looking expression.

If you have a non-emergency concern following treatment, you can contact Dr Nyla Medispa or call our team on 0800 009 6661. Symptoms suggestive of a medical emergency should be directed to 999.

If you are considering Botox and would like to discuss your suitability, treatment goals, potential risks, and an appropriate treatment plan, you can book a free consultation at our London, Cheshire, or Liverpool clinic.

About Dr Nyla Raja

Dr Nyla Raja MBChB (Hons), MRCGP (Dist), DFFP, DPDermatology is a GMC-registered doctor (GMC No. 6057913), a member of the British College of Aesthetic Medicine (BCAM) and the British Association of Cosmetic Doctors (BACD), and Founder and Medical Director of Dr Nyla Medispa. She has more than 20 years of clinical experience in aesthetic medicine, with an evidence-based approach focused on patient safety and natural-looking results.

Dr Nyla Medispa was named Best Clinic for Beauty and Safety in 2020 and an Aesthetic Awards Finalist in 2026, while Dr Nyla was nominated for Tatler’s Best Non-Surgical Facelift in 2025.

Considering treatment? Book a free consultation at our clinics in Mayfair London, Alderley Edge Cheshire, or Crosby Liverpool, or call 0800 009 6661.